NCT03164148

Heart Rate Variability (HRV) in Pituitary Adenoma

A Study to Observe the Change of the Biological Signal (Heart Rate) During the Combined Pituitary Stimulation Test

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Seoul St. Mary's Hospital · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

Several studies have been reported that heart rate is known to be associated with prognosis in chronic diseases and acute diseases. For example, a decrease in heart rate following myocardial infarction may lead to a higher mortality rate. It is also known to predict heart failure, diabetic neuropathy, and even depression. The combined pituitary function test artificially induces hypoglycemia to observe the secretion of pituitary hormone. The degree of change in heart rate during hypoglycemia can predict the adequacy of the test, and heart rate can be changed according to the characteristic of the tumor. Also, the prognosis can be predicted based on this. In our study, we used a licensed device approved by KFDA (Korea Food and Drug Administration) to measure heart rate variability in patients with pituitary adenoma.

Conditions

• Pituitary Adenoma

Interventions

Type	Name	Description
DEVICE	T-REX TRI00A	Case management consists of confirmation of hospital visit date, checking the adverse effect

Timeline

• Start date: 2017-05-17
• Primary completion: 2017-10-16
• Completion: 2018-05-16
• First posted: 2017-05-23
• Last updated: 2017-05-23

Locations

1 site across 1 country: South Korea